Elizabeth Weise, USA TODAY

Elizabeth Weise

USA TODAY

San Francisco, CA, United States

Contact Elizabeth

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • USA TODAY
  • Enquirer
Past:
  • The News Leader
  • El Paso Times
  • Burlington TimesNews
  • The Progress-Index
  • Tallahassee Democrat
  • Lansing StateJournal
  • The Tennessean
  • TCPalm
  • The Taunton Gazette
  • Times Record News
  • and more…

Recent articles by Elizabeth:

Is herd immunity to COVID-19 possible? Experts increasingly say no.

­­The United States may never reach full herd immunity against COVID-19 experts say, but vaccination can tame the coronavirus. → Read More

Halt on J&J COVID vaccine to continue until more data on rare blood clotting disorder is available

The CDC committee decided to leave a pause on J&J's COVID vaccine in place to gather more information on blood clots related to vaccinations. → Read More

COVID toes, Moderna arm, all-body rash: Vaccines can cause skin reactions but aren't dangerous, study says

A new study finds some COVID-19 vaccine skin reactions, including a measles-like rash and shingles, are rare, and thankfully brief, side effects. → Read More

New York launches nation's first 'vaccine passports.' Others are working on similar ideas, but many details must be worked out.

New York's new Excelsior Pass is part of a growing but disjointed effort to provide vaccine 'passports' or certifications useful for safe gatherings. → Read More

Clarity for Catholics: It's OK to get Johnson & Johnson COVID-19 vaccine – if it's the only one available

Catholics can get the Johnson & Johnson vaccine, despite its link to cells from an aborted fetus, if that's all that's available, Vatican says. → Read More

What if you had your choice of COVID-19 vaccine? Differences are small, but they do exist

If you get the choice, which COVID-19 vaccine should you choose? For now, any one you can get. But supply is growing, and there are differences. → Read More

What does victory against the COVID-19 pandemic look like? USA TODAY's vaccine panel weighs in

USA TODAY's panel of experts have different definitions of what the end of the pandemic means. But they agree it's getting closer. → Read More

America could soon be swimming in COVID-19 vaccine. The shift from scarcity to surplus could bring its own problems.

The abundance of vaccine will become a stagnating surplus that threatens to undermine the nation's ability to move beyond the pandemic, experts say. → Read More

Amid a chaotic COVID-19 vaccine rollout, states find ways to connect shots with arms

Under a decentralized national health care system and a chaotic COVID-19 vaccine rollout, states find their own ways to reach and vaccinate residents. → Read More

Want to hug again? Go to church? 'It's up to you,' Ad Council says in $500M campaign to promote COVID-19 vaccines

The ads are aimed at the 40% of Americans who haven’t yet made up their minds about getting vaccinated against COVID-19. → Read More

'Don't waste vaccine!' After early confusion, experts say it's always better to use leftover shots than toss them.

After early confusion, protocols for making sure leftover doses of COVID vaccine are used are largely in place. Experts say not to waste a shot. → Read More

'Don't waste vaccine!' After early confusion, experts say it's always better to use leftover shots than toss them.

After early confusion, protocols for making sure leftover doses of COVID vaccine are used are largely in place. Experts say not to waste a shot. → Read More

'Somewhere in there, the vaccine got overpromised': How the COVID-19 vaccination process turned chaotic and confusing

A lack of transparency, a federal-state disconnect and a short supply has complicated America's COVID-19 vaccine rollout. → Read More

A COVID-19 vaccine life cycle: from DNA to doses

Making a vaccine against the coronavirus is a complicated, months-long process. Pfizer is working to get it done faster. It still takes time. → Read More

Pfizer expects to cut COVID-19 vaccine production time by close to 50% as production ramps up, efficiencies increase

As the nation revs up its vaccination programs, the increase could help relieve bottlenecks caused by vaccine shortages. → Read More

Analysis: What went wrong with COVID vaccine distribution and how it has tarnished the 'miracle'

News analysis: The largest public vaccination effort ever was quickly tarnished. Even people leading the effort are at a loss to explain how and why. → Read More

'This is fantastic': Mass vaccination clinics to play key role in ending COVID-19 pandemic

High-volume vaccination centers will become common in US as the Biden administration seeks to vaccinate 1.5 million a day. → Read More

COVID-19 vaccine rollout hasn't worked, but change is coming, vaccine panel predicts

USA TODAY's expert vaccine panel is optimistic the nation's chaotic early vaccination effort should improve under the incoming Biden administration. → Read More

Where did COVID-19 come from?

As the U.S. marks one year since its first case, questions remain about the origin of the coronavirus that causes the disease. The answers matter. → Read More

Getting COVID-19 vaccine into the arms of Americans is off to a slow start; why the holdup?

More than 12.4 million doses of coronavirus vaccine have shipped to U.S. states but just over 2.5 million people received shots as of Wednesday. → Read More